Blueprint Medicines Co (NASDAQ:BPMC) Short Interest Up 6 7% in September kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
EFG Asset Management North America Corp. decreased its stake in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 18.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 90,124 shares of the biotechnology company’s stock after selling 20,017 shares during […]
Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) Director Jeffrey W. Albers sold 10,000 shares of the stock in a transaction on Friday, August 25th. The shares were sold at an average price of $50.16, for a total value of $501,600.00. Following the sale, the director now owns 176,050 shares of the company’s stock, valued […]
Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) Director Jeffrey W. Albers sold 10,000 shares of the company’s stock in a transaction dated Friday, August 25th. The shares were sold at an average price of $50.16, for a total transaction of $501,600.00. Following the transaction, the director now owns 176,050 shares in the company, valued […]
Blueprint Medicines Co. (NASDAQ:BPMC – Get Rating) was the recipient of a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 3,580,000 shares, a decline of 5.8% from the April 30th total of 3,800,000 shares. Based on an average trading volume of 598,200 shares, the […]